Alliance Pharma agrees £350m takeover bid
Alliance Pharma has accepted a £350m takeover bid from its largest shareholder DBAY Affiliates.
The Chippenham-headquartered healthcare group sells over-the-counter and prescription drugs around the world, with its brands including Kelo-Cote, Anbesol and Lypsyl.
The 62.5p-per-share, all-cash offer is at a 41% premium to last night's closing share price, and more than double the value when DBAY first made an approach to the Alliance board - in the wake of the chief executive Peter Butterfield departing and its annual results bei... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
